Suzanne Nasser s.n.nasser@keele.ac.uk
Suzanne Nasser s.n.nasser@keele.ac.uk
Elham A. Afify
Firas Kobeissy
Bassam Hamam
Ali H. Eid
Mahmoud M. El-Mas
Atherosclerosis-related cardiovascular diseases (CVDs) are the leading cause of death globally. Several lines of evidence are supportive of the contributory role of vascular inflammation in atherosclerosis. Diverse immune cell types, including monocytes/macrophages, T-cells and neutrophils, as well as specialized proresolving lipid mediators, have been successfully characterized as key players in vascular inflammation. The increased prevalence of atherosclerotic CVD in men in comparison to age-matched premenopausal women and the abolition of sex differences in prevalence during menopause strongly suggest a pivotal role of sex hormones in the development of CVD. Indeed, many animal and human studies conclusively implicate sex hormones as a crucial component in driving the immune response. This is further corroborated by the effective identification of sex hormone receptors in vascular endothelial cells, vascular smooth muscle cells and immune cells. Collectively, these findings suggest a cellular communication between sex hormones and vascular or immune cells underlying the vascular inflammation in atherosclerosis. The aim of this review is to provide an overview of vascular inflammation as a causal cue underlying atherosclerotic CVDs within the context of the modulatory effects of sex hormones. Moreover, the cellular and molecular signaling pathways underlying the sex hormones- immune system interactions as potential culprits for vascular inflammation are highlighted with detailed and critical discussion. Finally, the review concludes by speculations on the potential sex-related efficacy of currently available immunotherapies in mitigating vascular inflammation. Conceivably, a deeper understanding of the immunoregulatory influence of sex hormones on vascular inflammation-mediated atherosclerosis permits sex-based management of atherosclerosis-related CVDs.
Nasser, S. A., Afify, E. A., Kobeissy, F., Hamam, B., Eid, A. H., & El-Mas, M. M. (2021). Inflammatory Basis of Atherosclerosis: Modulation by Sex Hormones. Current Pharmaceutical Design, 27(18), 2099-2111. https://doi.org/10.2174/1381612827666210122142811
Journal Article Type | Review |
---|---|
Acceptance Date | Jan 22, 2021 |
Online Publication Date | Jan 22, 2021 |
Publication Date | 2021-05 |
Deposit Date | Jun 5, 2023 |
Journal | CURRENT PHARMACEUTICAL DESIGN |
Print ISSN | 1381-6128 |
Publisher | Bentham Science Publishers |
Peer Reviewed | Peer Reviewed |
Volume | 27 |
Issue | 18 |
Pages | 2099-2111 |
DOI | https://doi.org/10.2174/1381612827666210122142811 |
Estrogen and Bisphenol A in Hypertension
(2020)
Journal Article
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
Apache License Version 2.0 (http://www.apache.org/licenses/)
Apache License Version 2.0 (http://www.apache.org/licenses/)
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search